Reports
Sale
Asia Pacific Aortic Stent Graft Market Size, Share, Growth: By Product: Abdominal Aortic Stent Grafts, Thoracic Aortic Stent Grafts; By End User: Hospitals, Ambulatory Surgical Centers, Others; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, Key Demand Indicators, Others; Supplier Landscape; 2024-2032
Asia Pacific Aortic Stent Graft Market Outlook
The global aortic stent graft market size was valued at USD 3.1 billion in 2023, with Asia Pacific holding a significant market share. The market is driven by the growing aging population and the rising demand for minimally invasive surgeries. It is expected to grow at a CAGR of 5.8% during the forecast period of 2024-2032, with the values likely to attain USD 5.2 billion by 2032.
Key Takeaways
- The prevalence of aortic aneurysms and dissections (AAD) is estimated to be around 1-3% in the general population. However, in the older age groups, the prevalence increases to 10%. The growing aging population in the Asia Pacific region is expected to directly impact market demand.
- LifeTech Scientific Corporation reported that revenue generated from the sales of stent grafts till December 2023 witnessed an increase by 11.2%, reflecting a rise in the adoption of the device for treatment interventions. This growing preference for endovascular repair using aortic stent grafts is anticipated to boost the Asia Pacific aortic stent graft market share.
- One of the major market trends is the surge in approvals of new and advanced aortic stent graft systems. In July 2023, Terumo Aortic’s Thoraflex Hybrid frozen elephant trunk (FET) device received approval from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) for the treatment of complex aortic arch disease.
Asia Pacific Aortic Stent Graft Market Analysis
Aortic stent grafts are medical devices that are used in the treatment of aortic aneurysms (bulges in the wall of the aorta). They are designed to reinforce the weakened area in the aorta and prevent rupture of the aneurysm. The aortic stent graft is placed using an endovascular procedure (Endovascular aneurysm repair or thoracic endovascular aneurysm repair), which is less invasive compared to open surgery. The rising patient inclination towards such minimally invasive surgeries is expected to drive the Asia Pacific aortic stent graft market growth. Moreover, the increasing advancements in imaging and manufacturing technologies are also contributing to the growing acceptance of this medical device.
The Asia Pacific region is characterized by a rising aging population, particularly in countries like Japan where 29.1% of the 125 million population is aged 65 or over . The prevalence of aortic aneurysms and dissections (AAD) is estimated to be around 1-3% in the general population. However, in the older age groups, the prevalence increases to 10%. As the population ages, the risk for cardiovascular diseases including aortic aneurysms is likely to rise, which is poised to fuel the Asia Pacific aortic stent graft market demand in the forecast period.
LifeTech Scientific Corporation, a Chinese manufacturer of minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, announced the 2023 annual results, revealing the successful penetration of the company’s medical device products at different market levels in China including aortic stent grafts. Further, it was reported that revenue generated was increased by 11.2% from the sales of stent grafts for the year ended 31 December 2023, indicating an increased adoption of the devices for treatment interventions. The growing preference for endovascular repair using aortic stent grafts due to low procedural morbidity and mortality rates is anticipated to augment the market share.
One of the major Asia Pacific aortic stent graft market trends is the surge in approvals of new and advanced aortic stent graft systems. In July 2023, stent graft manufacturer Terumo Aortic announced that its Thoraflex Hybrid frozen elephant trunk (FET) device has received approval from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) for the commercial sale of the product in Japan for the treatment of complex aortic arch disease. The single-use medical device comprises Gelweave polyester graft with a Nitinol self-expanding stent graft and is employed for the open surgical repair or replacement of diseased or damaged vessels in cases of aneurysm or dissection. The rising introduction of such innovative stent grafts facilitated by the presence of a supportive regulatory framework is expected to bolster market growth.
Asia Pacific Aortic Stent Graft Market Segmentation
The report offers a detailed analysis of the market based on the following segments:
| Market Breakup | Categories |
| Product | Abdominal Aortic Stent Grafts, Thoracic Aortic Stent Grafts |
| End User | Hospitals, Ambulatory Surgical Centers, Others |
| Countries | China, Japan, ASEAN, Australia, India, Others |
Asia Pacific Aortic Stent Graft Market: Competitor Landscape
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Cook Medical, Inc.
- W.L. Gore & Associates
- MicroPort Scientific Corporation Inc.
- Medtronic Plc.
- Lombard Medical, Inc.
- Endologix, Inc.
- Terumo Corporation Inc.
- Cardinal Health Inc.
- Becton, Dickinson and Company
- CryoLife Inc.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Asia Pacific Aortic Stent Graft Market Overview
3.1 Asia Pacific Aortic Stent Graft Market Historical Value (2017-2023)
3.2 Asia Pacific Aortic Stent Graft Market Forecast Value (2024-2032)
4 Asia Pacific Aortic Stent Graft Market Landscape*
4.1 Asia Pacific Aortic Stent Graft: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Asia Pacific Aortic Stent Graft: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Type
4.2.3 Analysis by Application
5 Asia Pacific Aortic Stent Graft Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Asia Pacific Aortic Stent Graft Market Segmentation (2017-2032)
6.1 Asia Pacific Aortic Stent Graft Market (2017-2032) by Product
6.1.1 Market Overview
6.1.2 Abdominal Aortic Stent Grafts
6.1.3 Thoracic Aortic Stent Grafts
6.2 Asia Pacific Aortic Stent Graft Market (2017-2032) by End User
6.2.1 Market Overview
6.2.2 Hospitals
6.2.3 Ambulatory Surgical Centers
6.2.4 Others
6.3 Asia Pacific Aortic Stent Graft Market (2017-2032) by Countries
6.3.1 Market Overview
6.3.2 China
6.3.3 Japan
6.3.4 ASEAN
6.3.5 Australia
6.3.6 India
6.3.7 Others
7 China Aortic Stent Graft Market (2017-2032)
7.1 China of Aortic Stent Graft Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Abdominal Aortic Stent Grafts
7.1.3 Thoracic Aortic Stent Grafts
7.2 China of Aortic Stent Graft Market (2017-2032) by End User
7.2.1 Market Overview
7.2.2 Hospitals
7.2.3 Ambulatory Surgical Centers
7.2.4 Others
8 Japan Aortic Stent Graft Market (2017-2032)
8.1 Japan Aortic Stent Graft Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Abdominal Aortic Stent Grafts
8.1.3 Thoracic Aortic Stent Grafts
8.2 Japan Aortic Stent Graft Market (2017-2032) by End User
8.2.1 Market Overview
8.2.2 Hospitals
8.2.3 Ambulatory Surgical Centers
8.2.4 Others
9 ASEAN Aortic Stent Graft Market (2017-2032)
9.1 ASEAN Aortic Stent Graft Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Abdominal Aortic Stent Grafts
9.1.3 Thoracic Aortic Stent Grafts
9.2 ASEAN Aortic Stent Graft Market (2017-2032) by End User
9.2.1 Market Overview
9.2.2 Hospitals
9.2.3 Ambulatory Surgical Centers
9.2.4 Others
10 Australia Aortic Stent Graft Market (2017-2032)
10.1 Australia Aortic Stent Graft Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Abdominal Aortic Stent Grafts
10.1.3 Thoracic Aortic Stent Grafts
10.2 Australia Aortic Stent Graft Market (2017-2032) by End User
10.2.1 Market Overview
10.2.2 Hospitals
10.2.3 Ambulatory Surgical Centers
10.2.4 Others
11 India Aortic Stent Graft Market (2017-2032)
11.1 India Aortic Stent Graft Market (2017-2032) by Product
11.1.1 Market Overview
11.1.2 Abdominal Aortic Stent Grafts
11.1.3 Thoracic Aortic Stent Grafts
11.2 India Aortic Stent Graft Market (2017-2032) by End User
11.2.1 Market Overview
11.2.2 Hospitals
11.2.3 Ambulatory Surgical Centers
11.2.4 Others
12 Regulatory Framework
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Supplier Landscape
16.1 Market Share by Top 5 Companies
16.2 Cook Medical, Inc.
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 W.l. Gore & Associates
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 MicroPort Scientific Corporation Inc.
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 Medtronic Plc.
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 Lombard Medical, Inc.
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 Endologix, INC.
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 Terumo Corporation Inc.
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 Cardinal Health Inc.
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
16.10 Becton, Dickinson and Company
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
16.10.5 Certifications
16.11 Cryolife Inc.
16.11.1 Financial Analysis
16.11.2 Product Portfolio
16.11.3 Demographic Reach and Achievements
16.11.4 Mergers and Acquisitions
16.11.5 Certifications
17 Asia Pacific Aortic Stent Graft – Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The Asia Pacific aortic stent graft market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 5.8% during the forecast period of 2024-2032 and is likely to reach a market value of USD 5.2 billion by 2032.
The growing aging population and the rising demand for minimally invasive surgeries are fuelling the demand for the market.
One of the significant trends in the market is the surge in approvals of new and advanced aortic stent graft systems. In July 2023, Terumo Aortic’s Thoraflex Hybrid frozen elephant trunk (FET) device received approval from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) for the treatment of complex aortic arch disease.
Based on the product, the market is segmented into abdominal aortic stent grafts and thoracic aortic stent grafts.
End users of the market are hospitals and ambulatory surgical centers, among others.
The market segmentation by countries includes China, Japan, India, ASEAN, and Australia, among others.
The key players in the market are Cook Medical, Inc., W.L. Gore & Associates, MicroPort Scientific Corporation Inc., Medtronic Plc., Lombard Medical, Inc., Endologix, Inc., Terumo Corporation Inc., Cardinal Health Inc., Becton, Dickinson and Company, and CryoLife Inc.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2639
$2399
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 4399
$3999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 5829
$5299
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 6929
$6299
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER